Hims & Hers Scraps Compounded Weight Loss Pill Amid Regulatory Pressure

Hims & Hers Scraps Compounded Weight Loss Pill Amid Regulatory Pressure

2026-02-09 companies

San Francisco, Monday, 9 February 2026.
Yielding to FDA pressure and legal threats, Hims & Hers retracted its $49 compounded weight-loss pill just 48 hours after launch, exposing the regulatory volatility of the lucrative off-brand GLP-1 market.

Sources


Telehealth Pharmaceuticals